Geburtshilfe Frauenheilkd 2014; 74(3): 248-249
DOI: 10.1055/s-0034-1368262
Statement
GebFra Science
Georg Thieme Verlag KG Stuttgart · New York

Comment on the “Recommendations for the Diagnosis and Treatment of Endometrial Cancer-Update 2013” by G. Emons and P. Mallmann for the Uterus Commission of AGO

Stellungnahme zu den „Empfehlungen zur Diagnostik und Therapie des Endometriumkarzinoms – Update 2013“ von G. Emons und P. Mallmann für die Kommission Uterus der AGO
M. Kolben
1   Praxis für Frauengesundheit, Gräfelfing
,
C. Dannecker
2   Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Campus Großhadern, LMU München
,
R. Kürzl
3   Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Campus Innenstadt, LMU München
,
for the Uterine Malignancies Project Group of the Munich Tumor Center › Author Affiliations
Further Information

Publication History

Publication Date:
09 April 2014 (online)

Prior to starting work on the planned S3 guideline on the “Diagnosis and Treatment of Endometrial Cancer”, G. Emons and P. Mallmann, acting for the Uterus Commission of AGO, provided a summary of the current state of affairs [1]. The summary, which consisted of a brief outline of the main points, was discussed in detail by the Uterine Malignancies Project Group of the Munich Tumor Center, and two points in particular prompted the following comments:

 
  • References

  • 1 Emons G, Mallmann P. für die Kommission Uterus der AGO. Empfehlungen zur Diagnostik und Therapie des Endometriumkarzinoms – Update 2013. Frauenarzt 2013; 54: 660-664
  • 2 Dijkhuizen FP, Mol BW, Brölmann HA et al. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer 2000; 89: 1765
  • 3 ACOG. ACOG Committee Opinion No. 426: The role of transvaginal ultrasonography in the evaluation of postmenopausal bleeding. Obstet Gynecol 2009; 113 (2 Pt 1) 462-464